Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

medac gmbh - mycobacterium tuberculosi (= bcg) (= bacillus calmette-guerin) 2 10*8 cfu/dose - 3 10*9 cfu/dose - powder and solvent for intravesical suspension - tuberculins (bcg) - bcg vaccine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

msd belgium bv-srl - mycobacterium tuberculosi (= bcg) (= bacillus calmette-guerin) 2 10*8 cfu - 8 10*8 cfu - powder for intravesical suspension - tuberculins (bcg) - bcg vaccine

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not be administered to: - persons who have had a severe reaction (e.g., necrosis, blistering, anaphylactic shock, or ulcerations) to a previous tst, - persons with documented active tuberculosis or a clear history of treatment for tb infection or disease, (9) - persons with extensive burns or eczema.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol, tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (9) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied) tubersol should not

United States - English - NLM (National Library of Medicine)

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dermcare-vet pty. ltd. - allergenic extract - parenteral liquid/solution/suspension - allergenic extract ungrouped active 0.0 p - diagnostic agents - dog | bitch | castrate | puppy - diagnostic agent | allergy screen test | intradermal test | johne's diseases diagnosis | tuberculin test | tuberculosis detection

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tuberculin ppd is indicated as an aid in the detection of infection with mycobacterium tuberculosis . the standard tuberculin test employs the intradermal (mantoux) test using a 5 tu dose of tuberculin ppd.7 the 0.1 ml test dose of aplisol (tuberculin ppd, diluted) is equivalent to the 5 tu dose which has been clinically utilized and standardized with ppd-s. tuberculin skin testing is not contraindicated for persons who have been vaccinated with bcg and the skin-test results of such persons are used to support or exclude the diagnosis of m. tuberculosis infections.4 hiv infection is a strong risk factor for the development of tb disease in persons having tb infection. all hiv-infected persons should receive a ppd-tuberculin skin test.3 aplisol is contraindicated in patients with known hypersensitivity or allergy to aplisol or any of its components. aplisol should not be administered to persons who have previously experienced a severe reaction (e.g., vesiculation, ulceration, or necrosis) because of the sev

United States - English - NLM (National Library of Medicine)

tya pharmaceuticals - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tuberculin ppd is indicated as an aid in the detection of infection with . the standard tuberculin test employs the intradermal (mantoux) test using a 5 tu dose of tuberculin ppd. the 0.1 ml test dose of aplisol (tuberculin ppd, diluted) is equivalent to the 5 tu dose which has been clinically utilized and standardized with ppd-s. tuberculin skin testing is not contraindicated for persons who have been vaccinated with bcg and the skin-test results of such persons are used to support or exclude the diagnosis of infections. hiv infection is a strong risk factor for the development of tb disease in persons having tb infection. all hiv-infected persons should receive a ppd-tuberculin skin test. mycobacterium tuberculosis 7 m. tuberculosis 4 3 aplisol is contraindicated in patients with known hypersensitivity or allergy to aplisol or any of its components. aplisol should not be administered to persons who have previously experienced a severe reaction (e.g., vesiculation, ulceration, or

United States - English - NLM (National Library of Medicine)

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tuberculin ppd is indicated as an aid in the detection of infection with mycobacterium tuberculosis . the standard tuberculin test employs the intradermal (mantoux) test using a 5 tu dose of tuberculin ppd.7 the 0.1 ml test dose of aplisol (tuberculin ppd, diluted) is equivalent to the 5 tu dose which has been clinically utilized and standardized with ppd-s. tuberculin skin testing is not contraindicated for persons who have been vaccinated with bcg and the skin-test results of such persons are used to support or exclude the diagnosis of m. tuberculosis infections.4 hiv infection is a strong risk factor for the development of tb disease in persons having tb infection. all hiv-infected persons should receive a ppd-tuberculin skin test.3 aplisol is contraindicated in patients with known hypersensitivity or allergy to aplisol or any of its components. aplisol should not be administered to persons who have previously experienced a severe reaction (e.g., vesiculation, ulceration, or necrosis) because of the sev